<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57194">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02132533</url>
  </required_header>
  <id_info>
    <org_study_id>122013-063</org_study_id>
    <nct_id>NCT02132533</nct_id>
  </id_info>
  <brief_title>Nifedipine for Acute Tocolysis of Preterm Labor</brief_title>
  <acronym>Nifedipine</acronym>
  <official_title>Nifedipine for Acute Tocolysis of Preterm Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if nifedipine treatment of women in preterm labor
      receiving corticosteroids results in postponement of delivery when compared to placebo.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Percentage of women with preterm birth at less than 37 weeks of gestation</measure>
    <time_frame>Within 24 hours after delivery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of women with preterm birth within 48 hours of randomization</measure>
    <time_frame>Within 24 hours after delivery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of women with at least 2 doses of betamethasone administered prior to delivery</measure>
    <time_frame>Within 24 hours after delivery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of women with preterm birth within 7 days of randomization</measure>
    <time_frame>Within 24 hours after delivery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Preterm Labor</condition>
  <arm_group>
    <arm_group_label>Nifedipine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with preterm labor will receive nifedipine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with preterm labor will receive placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nifedipine</intervention_name>
    <description>Nifedipine 20 mg orally, then nifedipine 20 mg orally after 90 minutes if still contracting. Continue nifedipine 20 mg orally every 4 hours after the first dose for 48 hours.</description>
    <arm_group_label>Nifedipine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo orally, then placebo orally after 90 minutes if still contracting. Continue placebo orally every 4 hours after the first dose for 48 hours.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Usual evaluation, monitoring and care for women with preterm labor.</description>
    <arm_group_label>Nifedipine</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 18 and 44 years of age inclusive

          -  Singleton pregnancy

          -  Intact membranes

          -  Between 28-0/7 weeks and 33-6/7 weeks' gestation inclusive

          -  Uterine contractions of at least 1 in 10 minutes over 1 hour

          -  Cervical dilation between 2 cm and 4 cm inclusive

        Exclusion Criteria:

          -  Multifetal gestation

          -  Less than 28 weeks' gestation

          -  34 or more weeks' gestation

          -  Ruptured membranes

          -  More than 4 cm dilated

          -  Corticosteroids contraindicated per Parkland Hospital protocol

          -  Previously received a course of corticosteroids for fetal lung maturation

          -  Oligohydramnios

          -  Fetal growth restriction

          -  Chorioamnionitis or temperature of at least 38.0 degrees Celsius

          -  Fetal death

          -  Preeclampsia

          -  Suspected placental abruption or placenta previa

          -  Systolic BP &lt; 90 mmHg or diastolic BP &lt; 50 mmHg

          -  Baseline tachycardia (pulse &gt;120 after 2 consecutive measurements 30 minutes apart)

          -  Chronic hypertension treated with antihypertensives in pregnancy

          -  Seizure disorder or HIV

          -  Maternal allergy to nifedipine

          -  Known maternal cardiac disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josiah S Hawkins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian M Casey, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Donald D McIntire, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth J Leveno, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Josiah S Hawkins, MD</last_name>
    <phone>214-648-4746</phone>
    <email>josiah.hawkins@utsouthwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brian M Casey, MD</last_name>
    <phone>214-648-4746</phone>
    <email>brian.casey@utsouthwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Josiah S Hawkins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian M Casey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth J Leveno, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nifedipine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
